taiheng-凯发平台

tai heng appointed mr. jim fang as the new managing director to lead the company. mr. fang has more than 25 years’experience in us generic drug industry, including product development, manufacturing, product launch, commercialization, and portfolio management. his most recent position was the chief operating officer at stason pharmaceuticals inc., an us based specialty drug company. he will be responsible for developing and executing the company’s business strategies. "as one of chinese earliest companies ventured into us generic space, i have the full confidence for the company to face the challenge and be successful" ,said mr. fang when he officially joined the company on february 1^st, 2017.